Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
160.97
-1.20 (-0.74%)
At close: Jul 11, 2025, 4:00 PM
162.14
+1.17 (0.73%)
After-hours: Jul 11, 2025, 7:54 PM EDT
Cardinal Health Revenue
Cardinal Health had revenue of $54.88B in the quarter ending March 31, 2025, with 0.02% growth. This brings the company's revenue in the last twelve months to $222.29B, up 0.86% year-over-year. In the fiscal year ending June 30, 2024, Cardinal Health had annual revenue of $226.83B with 10.66% growth.
Revenue (ttm)
$222.29B
Revenue Growth
+0.86%
P/S Ratio
0.18
Revenue / Employee
$4,545,726
Employees
48,900
Market Cap
38.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 226.83B | 21.85B | 10.66% |
Jun 30, 2023 | 204.98B | 23.65B | 13.04% |
Jun 30, 2022 | 181.33B | 18.86B | 11.61% |
Jun 30, 2021 | 162.47B | 9.55B | 6.24% |
Jun 30, 2020 | 152.92B | 7.39B | 5.08% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CAH News
- 1 day ago - Cardinal Health announces One Voice Initiative to support independent pharmacy advocacy - PRNewsWire
- 13 days ago - Best Dividend Aristocrats For July 2025 - Seeking Alpha
- 4 weeks ago - Cardinal Health raises annual profit target - Reuters
- 4 weeks ago - Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day - PRNewsWire
- 4 weeks ago - Cardinal Health Analyst Flags Fading Scale Gap, Sees Rising Edge in Specialty Growth - Benzinga
- 5 weeks ago - Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system - PRNewsWire
- 6 weeks ago - Best Dividend Aristocrats For June 2025 - Seeking Alpha
- 2 months ago - 63 Top Dividend Growth Stocks For May 2025 - Seeking Alpha